Last week CNN published an investigative report that concluded that Avanir Pharmaceuticals was paying physicians to prescribe its drug, Neudexta, to Alzheimer’s patients under the pretext that these patients have a rare disease. CNN’s research revealed a 400% increase in the sale of Neudexta in the past four years, and Read More…
STAT, the on-line health publication covering medicine, science and health issues, recently sponsored an hour on-line “chat” with Reisa Sperling, the head of the Center for Alzheimer’s Research and Treatment at Brigham & Women’s Hospital. Dr. Sperling answered questions about the state of Alzheimer research and STAT reporters filled out Read More…
It appears that that the search for a cure for Alzheimer’s has stalled. Each summer the Alzheimer’s Association holds an international summit where researchers report on advances in the understanding of Alzheimer’s disease. This year, the gathering was notable for its lack of new information.
The paper that received the Read More…
The product in question will cost you $199. You believe it has the potential to profoundly change your sense of your future, 
and re-order your priorities. Should you buy it?
I am talking about the DNA testing kit marketed Read More…
The discouraging truth is that there is no cure for Alzheimer’s in sight. Drugs that have shown some promise, and theories about the influence of exercise, sleep, and diet on disease progression await further research. While there are many reasons why progress has been slow, one factor is the difficulty Read More…
